← Open Payments lookup

ALYSON NGUYEN: Open Payments

NPI 1801508106 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,204 in 288 payments from 21 companies in 2025. Trend: 2023 $466 · 2024 $4,022 · 2025 $7,204

Food & beverage: $7,204
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc28$1,073
ABBVIE INC.45$960
Neurocrine BioSciences, Inc.29$920
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)33$823
Teva Pharmaceuticals USA, Inc.40$719
Lundbeck LLC21$457
Vanda Pharmaceuticals Inc.19$444
Alkermes, Inc.13$415
Otsuka America Pharmaceutical, Inc.12$306
Axsome Therapeutics, Inc.11$257

Products named: VRAYLAR, INGREZZA, SPRAVATO, CAPLYTA, REXULTI, AUSTEDO XR, FANAPT, ARISTADA.

Industry payments across CA — which companies pay providers there.